Jonathan Kay to Logistic Models
This is a "connection" page, showing publications Jonathan Kay has written about Logistic Models.
Connection Strength
0.062
-
Curtis JR, Xie F, Kay J, Kallich JD. Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis. Arthritis Res Ther. 2019 12 12; 21(1):285.
Score: 0.033
-
Baecklund E, Backlin C, R?nnelid J, Toes R, Huizinga T, ?hlin E, Askling J, Hochberg FH, Klareskog L, Kay J, Smedby KE. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis. Scand J Rheumatol. 2018 07; 47(4):270-275.
Score: 0.029